185750.KS

Chong Kun Dang Pharmaceutical Corp. [185750.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

185750.KS Stock Summary

Top 185750.KS Correlated Resources

185750.KS


Top 10 Correlated Stocks

185750.KS


In the News

185750.KS Financial details

Company Rating
Strong Buy
Market Cap
1004.05B
Income
70.69B
Revenue
1453.16B
Book val./share
19493.01
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.34K
Optionable
No
Shortable
Yes
Earnings
08 Feb 2023
P/E
36.63
Forward P/E
-
PEG
-4.99
P/S
1.78
P/B
4.23
P/C
-
P/FCF
-81.33
Quick Ratio
-
Current Ratio
1.94
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.25K
EPS next Y
-
EPS next Q
-
EPS this Y
-95.19%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-38.71%
Revenue last 5Y
8.72%
Revenue Q/Q
4.88%
EPS Q/Q
23.28%
-
-
-
-
SMA20
-1.52%
SMA50
-5.99%
SMA100
-2.79%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.13%
Gross Margin
36%
Oper. Margin
7%
Profit Margin
5%
Payout
-
Shs Outstand
12.2M
Shs Float
7.36M
-
-
-
-
Target Price
-
52W Range
69523.81-99047.62
52W High
-16.81%
52W Low
+18.52%
RSI
46.24
Rel Volume
0.82
Avg Volume
16.27K
Volume
13.33K
Perf Week
-0.48%
Perf Month
-6.58%
Perf Quarter
-10.34%
Perf Half Y
-7.1%
-
-
-
-
Beta
1.09707
-
-
Volatility
524.89%, 2750.36%
Prev Close
-0.48%
Price
82400
Change
0.61%

185750.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
77.37K88.24K99.72K120.46K12.81K
Net income per share
4.71K3.91K4.98K8.47K407.25
Operating cash flow per share
7.15K3.93K7.14K9.64K123.01
Free cash flow per share
5.28K1.66K4.84K6.24K-371.22
Cash per share
3.98K4.24K8.53K14.96K1.79K
Book value per share
35.14K39.56K43.75K50.98K5.4K
Tangible book value per share
34.03K38.34K42.41K49.23K5.2K
Share holders equity per share
35.14K39.56K43.75K50.98K5.4K
Interest debt per share
9.27K9.89K11.2K12.94K2.3K
Market cap
1356.82B1011.03B922.8B1890.43B9682.18B
Enterprise value
1413.81B1069.56B963.94B1902.91B9787.42B
P/E ratio
25.2223.8517.1320.63226.64
Price to sales ratio
1.531.060.851.457.21
POCF ratio
16.6123.7211.9418.12750.33
PFCF ratio
22.4856.2117.628-248.64
P/B Ratio
3.382.361.953.4317.11
PTB ratio
3.382.361.953.4317.11
EV to sales
1.61.120.891.467.28
Enterprise value over EBITDA
14.1111.59.7412.6387.02
EV to operating cash flow
17.3125.0912.4718.24758.49
EV to free cash flow
23.4359.4618.3928.19-251.34
Earnings yield
0.040.040.060.050
Free cash flow yield
0.040.020.060.040
Debt to equity
0.050.110.050.10.24
Debt to assets
0.40.390.410.420.46
Net debt to EBITDA
0.570.630.420.080.94
Current ratio
1.641.911.71.872.08
Interest coverage
22.1627.9323.6732.0223.51
Income quality
1.521.011.431.140.3
Dividend Yield
0.010.010.0100
Payout ratio
0.160.20.160.10.25
Sales general and administrative to revenue
0.030.030.020.010.02
Research and developement to revenue
0.070.080.090.110.12
Intangibles to total assets
0.020.020.020.020.02
Capex to operating cash flow
-0.26-0.58-0.32-0.35-4.02
Capex to revenue
-0.02-0.03-0.02-0.03-0.04
Capex to depreciation
-0.97-1.16-1.08-1.55-1.89
Stock based compensation to revenue
00000
Graham number
61.01K59.01K70K98.57K7.03K
ROIC
0.170.150.140.20.13
Return on tangible assets
0.080.060.070.10.04
Graham Net
-15.42K-15.77K-14.76K-12.95K-1.73K
Working capital
142.86B185.82B194.07B279.49B346.92B
Tangible asset value
388.96B415.52B459.04B532.56B545B
Net current asset value
92.99B109.74B144.74B205.37B186.26B
Invested capital
0.260.240.250.250.42
Average receivables
00000
Average payables
107.65B106.36B123.04B144.12B136.72B
Average inventory
144.95B156.58B167.01B185.57B205.14B
Days sales outstanding
00000
Days payables outstanding
49.5243.4855.1364.6355.68
Days of inventory on hand
72.5880.8880.2783.2296.76
Receivables turnover
00000
Payables turnover
7.378.396.625.656.55
Inventory turnover
5.034.514.554.393.77
ROE
0.130.10.110.170.08
Capex per share
-1.87K-2.27K-2.3K-3.4K-494.23

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
30.32K11.52K10.86K11.65K12.22K
Net income per share
19049.9554.55736.91908.45
Operating cash flow per share
921.96-816.81204.96888.89108.66
Free cash flow per share
-77.37-1.22K-155.66615.82-251.04
Cash per share
20.47K5.96K000
Book value per share
50.34K18.01K18K18.59K19.49K
Tangible book value per share
48.51K17.35K18K18.57K19.46K
Share holders equity per share
50.34K18.01K18K18.59K19.49K
Interest debt per share
21.14K7.59K-20.25-77.98-62.14
Market cap
1295.53B3487.73B3091.83B2749.34B2469.69B
Enterprise value
1309.78B3592.97B3091.83B2749.34B2469.69B
P/E ratio
151556.0644.3629.6821.63
Price to sales ratio
3.799.649.067.516.43
POCF ratio
124.48-135.89480.0998.44723.35
PFCF ratio
-1.48K-90.81-632.14142.09-313.1
P/B Ratio
2.286.165.474.714.03
PTB ratio
2.286.165.474.714.03
EV to sales
3.839.939.067.516.43
Enterprise value over EBITDA
39.69300.2798.83123.6970.25
EV to operating cash flow
125.84-139.99480.0998.44723.35
EV to free cash flow
-1.5K-93.55-632.14142.09-313.1
Earnings yield
000.010.010.01
Free cash flow yield
0-0.0100.010
Debt to equity
0.260.24000
Debt to assets
0.480.460.470.470.45
Net debt to EBITDA
0.438.8000
Current ratio
2.072.081.991.871.94
Interest coverage
34.073.41-39.37-11-20.14
Income quality
4.85-16.370.371.210.12
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.010.010.290.290.26
Research and developement to revenue
0.10.14000
Intangibles to total assets
0.020.02000
Capex to operating cash flow
-1.080.5-1.76-0.31-3.31
Capex to revenue
-0.03-0.04-0.03-0.02-0.03
Capex to depreciation
-1.64-1.72-1.41-1.02-1.34
Stock based compensation to revenue
00000
Graham number
14.67K4.5K14.99K17.56K19.96K
ROIC
0.050.010.030.040.05
Return on tangible assets
000.020.020.03
Graham Net
-15.08K-5.77K-16.01K-16.35K-15.88K
Working capital
366.97B346.92B340.98B329.11B343.76B
Tangible asset value
547.6B545B000
Net current asset value
195.28B186.26B180.95B193.15B209.59B
Invested capital
0.420.42000
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
57.0149.02000
Days of inventory on hand
94.285.17000
Receivables turnover
00000
Payables turnover
1.581.84000
Inventory turnover
0.961.06000
ROE
000.030.040.05
Capex per share
-999.33-405.5-360.62-273.07-359.7

185750.KS Frequently Asked Questions

What is Chong Kun Dang Pharmaceutical Corp. stock symbol ?

Chong Kun Dang Pharmaceutical Corp. is a KR stock and trading under the symbol 185750.KS

What is Chong Kun Dang Pharmaceutical Corp. stock quote today ?

Chong Kun Dang Pharmaceutical Corp. stock price is $82400 today.

Is Chong Kun Dang Pharmaceutical Corp. stock public?

Yes, Chong Kun Dang Pharmaceutical Corp. is a publicly traded company.

Something similar